Unibest
← Back to patent-cliff list

CAS 1352227-15-6

(R)-4-(2-chloro-6-((methylthio)methyl)pyrimidin-4-yl)-3-methylmorpholine

Codes: AZD-6738-007

Application context (from source-drug indications)

Non-small cell lung cancerCeralasertibSmall cell lung cancerCeralasertib三阴性乳腺癌CeralasertibMelanomaCeralasertibSolid tumourCeralasertibOsteosarcomaCeralasertib

Source drugs (routes using this intermediate)

DrugTierExpiry
CeralasertibTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.